nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—Drug ineffective—Mesalazine—Crohn's disease	0.0638	0.0793	CcSEcCtD
Dexmedetomidine—Sinus tachycardia—Mesalazine—Crohn's disease	0.0275	0.0341	CcSEcCtD
Dexmedetomidine—Nephropathy—Mesalazine—Crohn's disease	0.0232	0.0289	CcSEcCtD
Dexmedetomidine—Sepsis—Mercaptopurine—Crohn's disease	0.0177	0.022	CcSEcCtD
Dexmedetomidine—Hypomagnesaemia—Mesalazine—Crohn's disease	0.0174	0.0217	CcSEcCtD
Dexmedetomidine—Pharyngolaryngeal pain—Mesalazine—Crohn's disease	0.0164	0.0204	CcSEcCtD
Dexmedetomidine—Laryngeal pain—Mesalazine—Crohn's disease	0.0162	0.0202	CcSEcCtD
Dexmedetomidine—Rigors—Azathioprine—Crohn's disease	0.0149	0.0185	CcSEcCtD
Dexmedetomidine—Pleural effusion—Mesalazine—Crohn's disease	0.0144	0.018	CcSEcCtD
Dexmedetomidine—Withdrawal syndrome—Prednisone—Crohn's disease	0.014	0.0174	CcSEcCtD
Dexmedetomidine—Gamma-glutamyltransferase increased—Mesalazine—Crohn's disease	0.0135	0.0167	CcSEcCtD
Dexmedetomidine—Delirium—Mesalazine—Crohn's disease	0.0129	0.016	CcSEcCtD
Dexmedetomidine—Hypocalcaemia—Mesalazine—Crohn's disease	0.0121	0.015	CcSEcCtD
Dexmedetomidine—Leukocytosis—Mesalazine—Crohn's disease	0.0118	0.0146	CcSEcCtD
Dexmedetomidine—Hypernatraemia—Prednisone—Crohn's disease	0.0111	0.0138	CcSEcCtD
Dexmedetomidine—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.0111	0.0138	CcSEcCtD
Dexmedetomidine—Blood urea increased—Mesalazine—Crohn's disease	0.0104	0.013	CcSEcCtD
Dexmedetomidine—Hepatic function abnormal—Azathioprine—Crohn's disease	0.0101	0.0125	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.00923	0.0115	CcSEcCtD
Dexmedetomidine—Malnutrition—Mercaptopurine—Crohn's disease	0.00891	0.0111	CcSEcCtD
Dexmedetomidine—Renal failure acute—Mesalazine—Crohn's disease	0.0087	0.0108	CcSEcCtD
Dexmedetomidine—Atrial fibrillation—Mesalazine—Crohn's disease	0.00848	0.0105	CcSEcCtD
Dexmedetomidine—Thirst—Mesalazine—Crohn's disease	0.00844	0.0105	CcSEcCtD
Dexmedetomidine—Anaemia—Mercaptopurine—Crohn's disease	0.00824	0.0102	CcSEcCtD
Dexmedetomidine—Neuritis—Prednisone—Crohn's disease	0.00784	0.00975	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00723	0.00899	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00712	0.00885	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00708	0.00881	CcSEcCtD
Dexmedetomidine—Abdominal distension—Mesalazine—Crohn's disease	0.00699	0.00869	CcSEcCtD
Dexmedetomidine—Pneumonia—Azathioprine—Crohn's disease	0.00684	0.0085	CcSEcCtD
Dexmedetomidine—Bronchospasm—Mesalazine—Crohn's disease	0.00683	0.00849	CcSEcCtD
Dexmedetomidine—Delirium—Prednisone—Crohn's disease	0.00681	0.00846	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00628	0.00781	CcSEcCtD
Dexmedetomidine—Leukocytosis—Prednisone—Crohn's disease	0.00623	0.00774	CcSEcCtD
Dexmedetomidine—Pneumonia—Mesalazine—Crohn's disease	0.00623	0.00774	CcSEcCtD
Dexmedetomidine—Haemoglobin—Azathioprine—Crohn's disease	0.00613	0.00762	CcSEcCtD
Dexmedetomidine—Haemorrhage—Azathioprine—Crohn's disease	0.0061	0.00758	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00607	0.00754	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Mesalazine—Crohn's disease	0.00602	0.00748	CcSEcCtD
Dexmedetomidine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00575	0.00715	CcSEcCtD
Dexmedetomidine—Haemoglobin—Mesalazine—Crohn's disease	0.00559	0.00694	CcSEcCtD
Dexmedetomidine—Fluid retention—Prednisone—Crohn's disease	0.00556	0.00691	CcSEcCtD
Dexmedetomidine—Haemorrhage—Mesalazine—Crohn's disease	0.00556	0.00691	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Azathioprine—Crohn's disease	0.0055	0.00683	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Mesalazine—Crohn's disease	0.00547	0.0068	CcSEcCtD
Dexmedetomidine—Chills—Azathioprine—Crohn's disease	0.00547	0.0068	CcSEcCtD
Dexmedetomidine—Arrhythmia—Azathioprine—Crohn's disease	0.00545	0.00677	CcSEcCtD
Dexmedetomidine—Pulmonary oedema—Prednisone—Crohn's disease	0.00521	0.00648	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Mesalazine—Crohn's disease	0.00516	0.00641	CcSEcCtD
Dexmedetomidine—Sepsis—Prednisone—Crohn's disease	0.00508	0.00631	CcSEcCtD
Dexmedetomidine—Angiopathy—Mesalazine—Crohn's disease	0.00504	0.00627	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Mesalazine—Crohn's disease	0.00501	0.00622	CcSEcCtD
Dexmedetomidine—Chills—Mesalazine—Crohn's disease	0.00499	0.0062	CcSEcCtD
Dexmedetomidine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00498	0.00619	CcSEcCtD
Dexmedetomidine—Anaemia—Azathioprine—Crohn's disease	0.00491	0.0061	CcSEcCtD
Dexmedetomidine—Mental disorder—Mesalazine—Crohn's disease	0.00487	0.00605	CcSEcCtD
Dexmedetomidine—Vomiting—Mercaptopurine—Crohn's disease	0.00463	0.00575	CcSEcCtD
Dexmedetomidine—Rash—Mercaptopurine—Crohn's disease	0.00459	0.0057	CcSEcCtD
Dexmedetomidine—Dermatitis—Mercaptopurine—Crohn's disease	0.00458	0.0057	CcSEcCtD
Dexmedetomidine—Anaemia—Mesalazine—Crohn's disease	0.00447	0.00556	CcSEcCtD
Dexmedetomidine—Nausea—Mercaptopurine—Crohn's disease	0.00432	0.00537	CcSEcCtD
Dexmedetomidine—Infection—Azathioprine—Crohn's disease	0.00431	0.00535	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Azathioprine—Crohn's disease	0.00424	0.00527	CcSEcCtD
Dexmedetomidine—Hypertension—Mesalazine—Crohn's disease	0.00418	0.00519	CcSEcCtD
Dexmedetomidine—Anxiety—Mesalazine—Crohn's disease	0.0041	0.0051	CcSEcCtD
Dexmedetomidine—Hypotension—Azathioprine—Crohn's disease	0.00405	0.00503	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Prednisone—Crohn's disease	0.00404	0.00502	CcSEcCtD
Dexmedetomidine—Dry mouth—Mesalazine—Crohn's disease	0.00403	0.00501	CcSEcCtD
Dexmedetomidine—Confusional state—Mesalazine—Crohn's disease	0.00398	0.00495	CcSEcCtD
Dexmedetomidine—Infection—Mesalazine—Crohn's disease	0.00392	0.00487	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Prednisone—Crohn's disease	0.00387	0.00481	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Mesalazine—Crohn's disease	0.00387	0.0048	CcSEcCtD
Dexmedetomidine—Tachycardia—Mesalazine—Crohn's disease	0.00385	0.00479	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Mesalazine—Crohn's disease	0.00382	0.00474	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00375	0.00466	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00374	0.00465	CcSEcCtD
Dexmedetomidine—Abdominal distension—Prednisone—Crohn's disease	0.0037	0.0046	CcSEcCtD
Dexmedetomidine—Hypotension—Mesalazine—Crohn's disease	0.00369	0.00459	CcSEcCtD
Dexmedetomidine—Sweating increased—Prednisone—Crohn's disease	0.00358	0.00445	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Azathioprine—Crohn's disease	0.00357	0.00444	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00354	0.00441	CcSEcCtD
Dexmedetomidine—Dyspnoea—Mesalazine—Crohn's disease	0.00352	0.00437	CcSEcCtD
Dexmedetomidine—Somnolence—Mesalazine—Crohn's disease	0.00351	0.00436	CcSEcCtD
Dexmedetomidine—Body temperature increased—Azathioprine—Crohn's disease	0.00343	0.00426	CcSEcCtD
Dexmedetomidine—Abdominal pain—Azathioprine—Crohn's disease	0.00343	0.00426	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00341	0.00424	CcSEcCtD
Dexmedetomidine—Pain—Mesalazine—Crohn's disease	0.00338	0.0042	CcSEcCtD
Dexmedetomidine—Constipation—Mesalazine—Crohn's disease	0.00338	0.0042	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Prednisone—Crohn's disease	0.00331	0.00412	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Mesalazine—Crohn's disease	0.00325	0.00404	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Prednisone—Crohn's disease	0.00323	0.00401	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00323	0.00401	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Prednisone—Crohn's disease	0.00321	0.00399	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Prednisone—Crohn's disease	0.00321	0.00399	CcSEcCtD
Dexmedetomidine—Abdominal pain—Mesalazine—Crohn's disease	0.00312	0.00388	CcSEcCtD
Dexmedetomidine—Body temperature increased—Mesalazine—Crohn's disease	0.00312	0.00388	CcSEcCtD
Dexmedetomidine—Bradycardia—Prednisone—Crohn's disease	0.00299	0.00372	CcSEcCtD
Dexmedetomidine—Diarrhoea—Azathioprine—Crohn's disease	0.00297	0.00369	CcSEcCtD
Dexmedetomidine—Haemoglobin—Prednisone—Crohn's disease	0.00296	0.00367	CcSEcCtD
Dexmedetomidine—Haemorrhage—Prednisone—Crohn's disease	0.00294	0.00365	CcSEcCtD
Dexmedetomidine—Hallucination—Prednisone—Crohn's disease	0.00293	0.00364	CcSEcCtD
Dexmedetomidine—Dizziness—Azathioprine—Crohn's disease	0.00287	0.00356	CcSEcCtD
Dexmedetomidine—Vomiting—Azathioprine—Crohn's disease	0.00276	0.00343	CcSEcCtD
Dexmedetomidine—Rash—Azathioprine—Crohn's disease	0.00273	0.0034	CcSEcCtD
Dexmedetomidine—Dermatitis—Azathioprine—Crohn's disease	0.00273	0.00339	CcSEcCtD
Dexmedetomidine—Headache—Azathioprine—Crohn's disease	0.00272	0.00337	CcSEcCtD
Dexmedetomidine—Diarrhoea—Mesalazine—Crohn's disease	0.0027	0.00336	CcSEcCtD
Dexmedetomidine—Angiopathy—Prednisone—Crohn's disease	0.00267	0.00332	CcSEcCtD
Dexmedetomidine—Arrhythmia—Prednisone—Crohn's disease	0.00263	0.00326	CcSEcCtD
Dexmedetomidine—Dizziness—Mesalazine—Crohn's disease	0.00261	0.00324	CcSEcCtD
Dexmedetomidine—Mental disorder—Prednisone—Crohn's disease	0.00258	0.0032	CcSEcCtD
Dexmedetomidine—Nausea—Azathioprine—Crohn's disease	0.00257	0.0032	CcSEcCtD
Dexmedetomidine—Malnutrition—Prednisone—Crohn's disease	0.00256	0.00318	CcSEcCtD
Dexmedetomidine—Vomiting—Mesalazine—Crohn's disease	0.00251	0.00312	CcSEcCtD
Dexmedetomidine—Rash—Mesalazine—Crohn's disease	0.00249	0.00309	CcSEcCtD
Dexmedetomidine—Dermatitis—Mesalazine—Crohn's disease	0.00249	0.00309	CcSEcCtD
Dexmedetomidine—Headache—Mesalazine—Crohn's disease	0.00247	0.00307	CcSEcCtD
Dexmedetomidine—Anaemia—Prednisone—Crohn's disease	0.00237	0.00294	CcSEcCtD
Dexmedetomidine—Agitation—Prednisone—Crohn's disease	0.00235	0.00292	CcSEcCtD
Dexmedetomidine—Nausea—Mesalazine—Crohn's disease	0.00235	0.00291	CcSEcCtD
Dexmedetomidine—Convulsion—Prednisone—Crohn's disease	0.00222	0.00276	CcSEcCtD
Dexmedetomidine—Hypertension—Prednisone—Crohn's disease	0.00221	0.00275	CcSEcCtD
Dexmedetomidine—Anxiety—Prednisone—Crohn's disease	0.00217	0.0027	CcSEcCtD
Dexmedetomidine—Infection—Prednisone—Crohn's disease	0.00208	0.00258	CcSEcCtD
Dexmedetomidine—Tachycardia—Prednisone—Crohn's disease	0.00204	0.00253	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Prednisone—Crohn's disease	0.00202	0.00251	CcSEcCtD
Dexmedetomidine—Constipation—Prednisone—Crohn's disease	0.00179	0.00222	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Prednisone—Crohn's disease	0.00172	0.00214	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Prednisone—Crohn's disease	0.00171	0.00212	CcSEcCtD
Dexmedetomidine—Body temperature increased—Prednisone—Crohn's disease	0.00165	0.00205	CcSEcCtD
Dexmedetomidine—Abdominal pain—Prednisone—Crohn's disease	0.00165	0.00205	CcSEcCtD
Dexmedetomidine—Diarrhoea—Prednisone—Crohn's disease	0.00143	0.00178	CcSEcCtD
Dexmedetomidine—Dizziness—Prednisone—Crohn's disease	0.00138	0.00172	CcSEcCtD
Dexmedetomidine—Vomiting—Prednisone—Crohn's disease	0.00133	0.00165	CcSEcCtD
Dexmedetomidine—Rash—Prednisone—Crohn's disease	0.00132	0.00164	CcSEcCtD
Dexmedetomidine—Dermatitis—Prednisone—Crohn's disease	0.00132	0.00164	CcSEcCtD
Dexmedetomidine—Headache—Prednisone—Crohn's disease	0.00131	0.00163	CcSEcCtD
Dexmedetomidine—Nausea—Prednisone—Crohn's disease	0.00124	0.00154	CcSEcCtD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—PTGER4—Crohn's disease	0.000247	0.00126	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PLA2G4F—Crohn's disease	0.000245	0.00126	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—GPR65—Crohn's disease	0.000245	0.00125	CbGpPWpGaD
Dexmedetomidine—ADRA2B—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000238	0.00122	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ACKR2—Crohn's disease	0.000237	0.00121	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—CCR6—Crohn's disease	0.000236	0.00121	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—RSPO3—Crohn's disease	0.000236	0.00121	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—ITGA4—Crohn's disease	0.000234	0.0012	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—CCR6—Crohn's disease	0.000233	0.00119	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CCR6—Crohn's disease	0.00023	0.00118	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—IL3—Crohn's disease	0.000228	0.00117	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCR9—Crohn's disease	0.000227	0.00116	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	0.000225	0.00115	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MLN—Crohn's disease	0.000224	0.00115	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—PTGER4—Crohn's disease	0.000224	0.00115	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—SEL1L—Crohn's disease	0.000224	0.00115	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Platelet activation, signaling and aggregation—ALB—Crohn's disease	0.000224	0.00115	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—PTGER4—Crohn's disease	0.000223	0.00114	CbGpPWpGaD
Dexmedetomidine—ADRA2C—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000223	0.00114	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—RSPO3—Crohn's disease	0.000221	0.00113	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—RASGRP1—Crohn's disease	0.00022	0.00113	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—RSPO3—Crohn's disease	0.000217	0.00111	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CCR6—Crohn's disease	0.000215	0.0011	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PLA2G4F—Crohn's disease	0.000212	0.00109	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CCR6—Crohn's disease	0.000211	0.00108	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—GPR65—Crohn's disease	0.000211	0.00108	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—IL2RA—Crohn's disease	0.00021	0.00108	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—IL3—Crohn's disease	0.00021	0.00108	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00021	0.00107	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—SEL1L—Crohn's disease	0.000209	0.00107	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—MTMR3—Crohn's disease	0.000209	0.00107	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—PTGER4—Crohn's disease	0.000208	0.00106	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	0.000208	0.00106	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—SEL1L—Crohn's disease	0.000206	0.00105	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TAGAP—Crohn's disease	0.000205	0.00105	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCR9—Crohn's disease	0.000205	0.00105	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—PTGER4—Crohn's disease	0.000205	0.00105	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000203	0.00104	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—PTGER4—Crohn's disease	0.000202	0.00104	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000201	0.00103	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—FADS1—Crohn's disease	0.0002	0.00102	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—IL2RA—Crohn's disease	0.000196	0.00101	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CCR6—Crohn's disease	0.000192	0.000982	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—MTMR3—Crohn's disease	0.000192	0.00098	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCR9—Crohn's disease	0.000191	0.000979	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL3—Crohn's disease	0.000191	0.000977	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—GPR65—Crohn's disease	0.000191	0.000975	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—IL3—Crohn's disease	0.00019	0.000971	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000189	0.000969	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—PTGER4—Crohn's disease	0.000189	0.000967	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000189	0.000965	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCR9—Crohn's disease	0.000188	0.000964	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—GPX4—Crohn's disease	0.000187	0.000959	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—PTGER4—Crohn's disease	0.000186	0.000952	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—RASGRP1—Crohn's disease	0.000185	0.000944	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000184	0.000939	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—GCKR—Crohn's disease	0.000181	0.000926	CbGpPWpGaD
Dexmedetomidine—ADRA2A—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000181	0.000925	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—MTMR3—Crohn's disease	0.000181	0.000924	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RSPO3—Crohn's disease	0.000179	0.000917	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—GPR65—Crohn's disease	0.000178	0.00091	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—IL3—Crohn's disease	0.000177	0.000907	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000177	0.000906	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—GPR65—Crohn's disease	0.000175	0.000896	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—IL3—Crohn's disease	0.000174	0.000893	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CCR6—Crohn's disease	0.000174	0.000892	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000174	0.000891	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL3—Crohn's disease	0.000172	0.000882	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000171	0.000877	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—SEL1L—Crohn's disease	0.00017	0.00087	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000169	0.000865	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000169	0.000863	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—RASGRP1—Crohn's disease	0.000167	0.000853	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—FADS1—Crohn's disease	0.000163	0.000832	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL3—Crohn's disease	0.000161	0.000824	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.00016	0.000818	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR ligand binding—CXCL8—Crohn's disease	0.00016	0.000818	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—IL2RA—Crohn's disease	0.00016	0.000816	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000159	0.000815	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL3—Crohn's disease	0.000158	0.000811	CbGpPWpGaD
Dexmedetomidine—SLC6A2—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000157	0.000802	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—RASGRP1—Crohn's disease	0.000156	0.000797	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCR9—Crohn's disease	0.000155	0.000795	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—PTGER4—Crohn's disease	0.000153	0.000785	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—RASGRP1—Crohn's disease	0.000153	0.000784	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—GPX4—Crohn's disease	0.000152	0.000779	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—ALB—Crohn's disease	0.000152	0.000778	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCR6—Crohn's disease	0.00015	0.000769	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—FADS1—Crohn's disease	0.000149	0.000764	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—IL2RA—Crohn's disease	0.000147	0.000753	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—GCKR—Crohn's disease	0.000147	0.000752	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—GPR65—Crohn's disease	0.000145	0.00074	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—CXCL8—Crohn's disease	0.000144	0.000738	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—IL3—Crohn's disease	0.000144	0.000737	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000144	0.000736	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—ALB—Crohn's disease	0.000142	0.000727	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—JAK2—Crohn's disease	0.000141	0.000723	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—FADS1—Crohn's disease	0.000141	0.00072	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—GPX4—Crohn's disease	0.00014	0.000715	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000139	0.000712	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—RBX1—Crohn's disease	0.000136	0.000696	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.000136	0.000696	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCR6—Crohn's disease	0.000136	0.000695	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	0.000135	0.000693	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—GCKR—Crohn's disease	0.000135	0.000691	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—CXCL8—Crohn's disease	0.000135	0.00069	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL2RA—Crohn's disease	0.000134	0.000684	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—IL2RA—Crohn's disease	0.000133	0.00068	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—CXCL8—Crohn's disease	0.000133	0.000679	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PTGER4—Crohn's disease	0.000132	0.000677	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000132	0.000676	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—JAK2—Crohn's disease	0.000132	0.000676	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—GPX4—Crohn's disease	0.000132	0.000674	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL3—Crohn's disease	0.000131	0.000669	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—GCKR—Crohn's disease	0.000127	0.000651	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCR6—Crohn's disease	0.000127	0.000649	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000126	0.000647	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCR6—Crohn's disease	0.000125	0.000638	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—IL2RA—Crohn's disease	0.000124	0.000635	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—RBX1—Crohn's disease	0.000123	0.000628	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—IL2RA—Crohn's disease	0.000122	0.000625	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL2RA—Crohn's disease	0.000121	0.000618	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PTGER4—Crohn's disease	0.00012	0.000611	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—UBE2D1—Crohn's disease	0.000119	0.00061	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—RIPK2—Crohn's disease	0.000116	0.000592	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—ALB—Crohn's disease	0.000115	0.00059	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—MTMR3—Crohn's disease	0.000115	0.000589	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—RBX1—Crohn's disease	0.000115	0.000587	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—RBX1—Crohn's disease	0.000113	0.000577	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL2RA—Crohn's disease	0.000113	0.000577	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL3—Crohn's disease	0.000113	0.000577	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PTGER4—Crohn's disease	0.000112	0.000571	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL2RA—Crohn's disease	0.000111	0.000568	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PTGER4—Crohn's disease	0.00011	0.000562	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—CXCL8—Crohn's disease	0.000109	0.00056	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—RASGRP1—Crohn's disease	0.000109	0.000558	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—UBE2D1—Crohn's disease	0.000108	0.000551	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—JAK2—Crohn's disease	0.000107	0.000549	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—FADS1—Crohn's disease	0.000106	0.000542	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—RIPK2—Crohn's disease	0.000104	0.000534	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	0.000103	0.000527	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL3—Crohn's disease	0.000102	0.000521	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000101	0.000516	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—UBE2D1—Crohn's disease	0.000101	0.000514	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GPX4—Crohn's disease	9.92e-05	0.000507	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—UBE2D1—Crohn's disease	9.9e-05	0.000506	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—JAK2—Crohn's disease	9.9e-05	0.000506	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—SOCS1—Crohn's disease	9.88e-05	0.000505	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—RASGRP1—Crohn's disease	9.85e-05	0.000504	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—RIPK2—Crohn's disease	9.75e-05	0.000499	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—RIPK2—Crohn's disease	9.6e-05	0.000491	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GCKR—Crohn's disease	9.58e-05	0.00049	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL3—Crohn's disease	9.51e-05	0.000486	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—TYK2—Crohn's disease	9.42e-05	0.000482	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL3—Crohn's disease	9.36e-05	0.000479	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	9.31e-05	0.000477	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—RASGRP1—Crohn's disease	9.2e-05	0.000471	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	9.16e-05	0.000469	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	9.09e-05	0.000465	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	9.07e-05	0.000464	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—RASGRP1—Crohn's disease	9.05e-05	0.000463	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—CXCL8—Crohn's disease	9.03e-05	0.000462	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—JAK2—Crohn's disease	8.99e-05	0.00046	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—FADS1—Crohn's disease	8.97e-05	0.000459	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—JAK2—Crohn's disease	8.93e-05	0.000457	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—SOCS1—Crohn's disease	8.92e-05	0.000456	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	8.53e-05	0.000436	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—TYK2—Crohn's disease	8.5e-05	0.000435	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GPX4—Crohn's disease	8.4e-05	0.00043	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	8.35e-05	0.000427	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	8.33e-05	0.000426	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	8.21e-05	0.00042	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	8.2e-05	0.00042	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	8.2e-05	0.00042	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	8.17e-05	0.000418	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—CXCL8—Crohn's disease	8.15e-05	0.000417	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GCKR—Crohn's disease	8.11e-05	0.000415	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—JAK2—Crohn's disease	8.11e-05	0.000415	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.96e-05	0.000407	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	7.94e-05	0.000406	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	7.92e-05	0.000405	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	7.9e-05	0.000404	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	7.82e-05	0.0004	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL3—Crohn's disease	7.72e-05	0.000395	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—SMAD3—Crohn's disease	7.7e-05	0.000394	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	7.62e-05	0.00039	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	7.58e-05	0.000388	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	7.5e-05	0.000384	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	7.47e-05	0.000382	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	7.46e-05	0.000382	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	7.4e-05	0.000379	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	7.19e-05	0.000368	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	7.13e-05	0.000365	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	7.08e-05	0.000362	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	6.92e-05	0.000354	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	6.81e-05	0.000348	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	6.78e-05	0.000347	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	6.77e-05	0.000346	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	6.66e-05	0.000341	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	6.56e-05	0.000335	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	6.45e-05	0.00033	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	6.19e-05	0.000317	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	6.16e-05	0.000315	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	5.84e-05	0.000299	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.8e-05	0.000297	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—ALB—Crohn's disease	5.76e-05	0.000295	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	5.62e-05	0.000287	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	5.56e-05	0.000285	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	5.41e-05	0.000277	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	5.31e-05	0.000272	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.07e-05	0.00026	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PTGS2—Crohn's disease	5.04e-05	0.000258	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	5.02e-05	0.000257	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	4.85e-05	0.000248	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	4.79e-05	0.000245	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	4.69e-05	0.00024	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—ALB—Crohn's disease	4.68e-05	0.000239	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	4.62e-05	0.000236	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	4.61e-05	0.000236	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	4.48e-05	0.000229	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	4.41e-05	0.000225	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	4.37e-05	0.000224	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ALB—Crohn's disease	4.3e-05	0.00022	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	4.16e-05	0.000213	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PTGS2—Crohn's disease	4.09e-05	0.000209	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	4.09e-05	0.000209	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ALB—Crohn's disease	4.05e-05	0.000207	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	4.02e-05	0.000206	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	3.9e-05	0.000199	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	3.89e-05	0.000199	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	3.82e-05	0.000196	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	3.81e-05	0.000195	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PTGS2—Crohn's disease	3.76e-05	0.000192	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	3.64e-05	0.000186	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PTGS2—Crohn's disease	3.54e-05	0.000181	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	3.52e-05	0.00018	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	3.32e-05	0.00017	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	3.29e-05	0.000168	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	3.23e-05	0.000165	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	3.16e-05	0.000161	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ALB—Crohn's disease	3.05e-05	0.000156	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL6—Crohn's disease	2.72e-05	0.000139	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	2.67e-05	0.000137	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.67e-05	0.000136	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ALB—Crohn's disease	2.58e-05	0.000132	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6—Crohn's disease	2.46e-05	0.000126	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6—Crohn's disease	2.3e-05	0.000117	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.26e-05	0.000116	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6—Crohn's disease	2.26e-05	0.000116	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6—Crohn's disease	1.86e-05	9.54e-05	CbGpPWpGaD
